Navigation Links
Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference
Date:11/11/2011

NEW YORK, Nov. 11, 2011 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the Lazard Capital Markets 8th Annual Healthcare Conference, being held at the Pierre Hotel in New York City. Mr. Bentsur's presentation is scheduled to take place on Wednesday, November 16, 2011, at 9:00 a.m. ET.

A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website at http://investors.keryx.com. An archived version of the webcast will be available following the conclusion of the live presentation.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 is currently in Phase 3 clinical development for both refractory advanced colorectal cancer and multiple myeloma, and in Phase 1 and 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 studies is being conducted under a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevat
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
2. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
3. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
4. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results
5. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
7. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
8. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
9. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2010 Financial Results
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year End 2010 Financial Results on Wednesday, March 9, 2011 at 8:30 a.m. ET
11. Keryx Biopharmaceuticals Announces Oral Presentation of Final Zerenex™ Short-Term Phase 3 Data at the Upcoming National Kidney Foundations 2011 Spring Clinical Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  AMETEK, Inc. (NYSE: ... Kurtis L. Goos as Vice President and ... Interconnects and Packaging (EMIP) Division. "I am ... general management and business development experience, especially in the ... important contributions to the continued growth and success of ...
(Date:7/25/2014)... , July 25, 2014 Leading ... is returning for the seventh year to São Paulo, ... 7 th August 2014. The event will co-locate with ... most comprehensive meeting point for the pharmaceutical industry. ... top 25 countries for pharmaceutical sales are now exploring the ...
(Date:7/25/2014)... July 25, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ... corporate update and report second quarter 2014 financial results ... August 1, 2014. That same day, Arena will host ... Time (5:30 a.m. Pacific Time). The ... domestic callers and 914.495.8552 for international callers. Please specify ...
Breaking Medicine Technology:AMETEK Names Kurtis L. Goos, Vice President & General Manager, Engineered Medical Components 2CPhI South America 2014 Launches with Generics Showing Huge Growth 2CPhI South America 2014 Launches with Generics Showing Huge Growth 3CPhI South America 2014 Launches with Generics Showing Huge Growth 4Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3
... Nov. 4 HeartWare International, Inc. (Nasdaq: HTWR ... less invasive, miniaturized circulatory support technologies revolutionizing the treatment ... in revenues to $7.5 million for the third quarter ... million in revenues in the second quarter ended June ...
... , THOUSAND OAKS, Calif., Nov. 4 Amgen (Nasdaq: ... applications for its 19th annual Amgen Award for Science ... recognize and honor extraordinary science teachers at the K-12 ... teaching and who achieve demonstrated results in student learning ...
Cached Medicine Technology:HeartWare International Reports Third Quarter Revenues of $7.5 Million 2HeartWare International Reports Third Quarter Revenues of $7.5 Million 3HeartWare International Reports Third Quarter Revenues of $7.5 Million 4HeartWare International Reports Third Quarter Revenues of $7.5 Million 5HeartWare International Reports Third Quarter Revenues of $7.5 Million 6HeartWare International Reports Third Quarter Revenues of $7.5 Million 7Call for Applications: The Amgen Award for Science Teaching Excellence 2Call for Applications: The Amgen Award for Science Teaching Excellence 3
(Date:7/25/2014)... Steven Reinberg HealthDay Reporter , ... number of girls and boys are getting the human papillomavirus ... U.S. health officials said Thursday. The U.S. Centers for ... 11 and 12 get the three-dose vaccine so that protection ... Yet, despite a slight increase over the year ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Project Ninety ... episode of Innovations with Ed Begley Jr, airing later ... times TBA. , For more than four decades, Project ... Area community through its residential alcohol and substance abuse ... on Project Ninety's humble idea and how it has ...
(Date:7/25/2014)... July 25, 2014 ZeptoMetrix™ Corporation ... reliable and trusted products and services for infectious ... release of NATtrol™ RP Multimarker Controls - ... in vitro diagnostic, CE marked, unassayed external run ... assays the NATtrol™ RP Multimarker Controls - MDZ001 ...
(Date:7/25/2014)... Brighton, MI (PRWEB) July 25, 2014 In ... political uncertainty, it’s no surprise that Americans may not be ... with it, according to a new poll conducted by ... 200 consumers from across the country, “Which Political Party Do ... Night?” found that those registered as Independents tout a higher ...
(Date:7/25/2014)... NY (PRWEB) July 25, 2014 Ticket ... the Guinness International Champions Cup Match between Manchester City ... New York, one of the most iconic locations is Yankee ... Yankee Stadium, but it is quickly becoming a location that ... facility is home to the New York Yankees from Major ...
Breaking Medicine News(10 mins):Health News:Too Few Teens Receive HPV Shot, CDC Says 2Health News:Too Few Teens Receive HPV Shot, CDC Says 3Health News:Project Ninety to be Featured on Innovations with Ed Begley, Jr. 2Health News:Project Ninety to be Featured on Innovations with Ed Begley, Jr. 3Health News:ZeptoMetrix™ Corporation (ZMC) Releases FDA Class 1 Exempt, IVD and CE Labeled NATtrol™ RP Multimarker Controls 2Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 2Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 3Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 3
... Saint Louis University researcher confirms findings that about half of ... causes them to metabolize food// differently, putting them at greater ... assistant professor of nutrition and dietetics at Doisy College of ... common version of a gene called FABP2, which is involved ...
... conclusively that a neuropeptide, melanin concentrating hormone (MCH), found ... increasing appetite in people, plays a role in the ... insulin. This finding has the potential to spur the ... production of insulin-producing beta cells in the pancreas. ...
... Complications due to drinking during pregnancy can range from ... severe and possibly greater-occurring Fetal Alcohol// Spectrum Disorders. The ... and type, all appear to be crucial elements of ... 80 percent of non-Indigenous West Australian women consumed alcohol ...
... six global acquisitions last year, India's Ranbaxy Laboratories has entered ... German// pharmaceuticals major Merck in a deal estimated at over ... equity funds to finance the deal,’ Ranbaxy's chief executive Malvinder ... the World Economic Forum (WEF) here. ‘We are being hounded ...
... Varenicline is the first new anti-smoking drug in the last ... to be licensed in the USA for smoking cessation. ... for use in the UK on 5th December 2006. An ... give a three-fold increase in the odds of a person ...
... number of women aged 40 and older are getting mammography ... more breast cancer deaths down the line, according to concerned ... 1990s, and scientists are disturbed about this decline. ... a test that's been around for a long time, it's ...
Cached Medicine News:Health News:Role of Appetite Hormone MCH in Insulin Production Revealed 2Health News:Risk Factors of Drinking Before, and During, Pregnancy 2Health News:Mammography Saves Life-Beware Women Over 40 2
The True Non-Compliant Balloon....
... Medical's universal programmer platform, the Model ... combination with St. Jude Medical® bradycardia ... emerging indications. Features a large, ... matrix LCD screen Programmer offers continuous, ...
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... Digital Multichannel, with it's streamlined ... of routine laboratory tasks. The ... features: Soft-touch tip ejection, Super ... (0.5-10ul models), Entire pipette autoclavable, ...
Medicine Products: